Head to Head Contrast: Colgate-Palmolive (CL) vs. Its Competitors
Colgate-Palmolive (NYSE: CL) is one of 32 publicly-traded companies in the “Personal Products” industry, but how does it weigh in compared to its rivals? We will compare Colgate-Palmolive to similar companies based on the strength of its valuation, profitability, institutional ownership, risk, dividends, analyst recommendations and earnings.
Insider and Institutional Ownership
73.2% of Colgate-Palmolive shares are owned by institutional investors. Comparatively, 57.6% of shares of all “Personal Products” companies are owned by institutional investors. 1.0% of Colgate-Palmolive shares are owned by insiders. Comparatively, 15.4% of shares of all “Personal Products” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Colgate-Palmolive pays an annual dividend of $1.60 per share and has a dividend yield of 2.2%. Colgate-Palmolive pays out 59.5% of its earnings in the form of a dividend. As a group, “Personal Products” companies pay a dividend yield of 2.0% and pay out 46.2% of their earnings in the form of a dividend. Colgate-Palmolive has raised its dividend for 53 consecutive years.
This is a breakdown of recent recommendations for Colgate-Palmolive and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Colgate-Palmolive presently has a consensus target price of $74.80, indicating a potential upside of 3.96%. As a group, “Personal Products” companies have a potential downside of 0.71%. Given Colgate-Palmolive’s higher probable upside, equities research analysts clearly believe Colgate-Palmolive is more favorable than its rivals.
This table compares Colgate-Palmolive and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation and Earnings
This table compares Colgate-Palmolive and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Colgate-Palmolive||$15.18 billion||$4.42 billion||26.75|
|Colgate-Palmolive Competitors||$14.46 billion||$2.91 billion||14.11|
Colgate-Palmolive has higher revenue and earnings than its rivals. Colgate-Palmolive is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Colgate-Palmolive has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Colgate-Palmolive’s rivals have a beta of 1.09, indicating that their average share price is 9% more volatile than the S&P 500.
Colgate-Palmolive beats its rivals on 9 of the 15 factors compared.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company’s oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy’s Oil Soap. The Company, through its Hill’s Pet Nutrition segment (Hill’s), manufactures pet nutrition products for dogs and cats.
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.